Company profile for Be Biopharma

NEW Drugs in Dev: 1
PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Be Bio is a leader in developing engineered B cells as a new category of cellular medicines. B cells are one of the most unique and versatile populations of cells in the body, playing a key role in humoral immunity and in modulating immune cell behavior in tumors and chronically inflamed tissues. They are among the human body’s most prolific secreted protein factories, they traffic to tissues in a targetable fashion, and the...
Be Bio is a leader in developing engineered B cells as a new category of cellular medicines. B cells are one of the most unique and versatile populations of cells in the body, playing a key role in humoral immunity and in modulating immune cell behavior in tumors and chronically inflamed tissues. They are among the human body’s most prolific secreted protein factories, they traffic to tissues in a targetable fashion, and they can engraft in niches for as long as decades. Our goal is to harness B cells’ rich biology and intrinsic drug-like properties by precisely engineering them to forge a new category of cell therapy.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
One Kendall Sq. B200, Suite 001 Cambridge, MA 02139
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20250730482488/en/Be-Bio-Announces-First-Participant-Dosed-in-BeCoMe-9-Trial-of-BE-101-in-Hemophilia-B

BUSINESSWIRE
30 Jul 2025

https://www.businesswire.com/news/home/20250517132804/en/Be-Biopharma-Announces-New-Preclinical-Data-for-BE-102-a-B-Cell-Medicine-for-the-Potential-Treatment-of-Hypophosphatasia

BUSINESSWIRE
17 May 2025

https://www.businesswire.com/news/home/20250428532199/en/Be-Biopharma-to-Present-at-the-American-Society-of-Gene-and-Cell-Therapy-ASGCT-28th-Annual-Meeting

BUSINESSWIRE
28 Apr 2025

https://www.businesswire.com/news/home/20250303787897/en

BUSINESSWIRE
03 Mar 2025

https://www.businesswire.com/news/home/20250206899836/en

BUSINESSWIRE
06 Feb 2025

https://www.businesswire.com/news/home/20250115202555/en

BUSINESSWIRE
15 Jan 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty